These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34697091)

  • 1. Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.
    Kim N; Kwak G; Rodriguez J; Livraghi-Butrico A; Zuo X; Simon V; Han E; Shenoy SK; Pandey N; Mazur M; Birket SE; Kim A; Rowe SM; Boucher R; Hanes J; Suk JS
    Thorax; 2022 Aug; 77(8):812-820. PubMed ID: 34697091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice.
    Pieper M; Schulz-Hildebrandt H; Mall MA; Hüttmann G; König P
    Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L518-L524. PubMed ID: 31994896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.
    Suk JS; Kim AJ; Trehan K; Schneider CS; Cebotaru L; Woodward OM; Boylan NJ; Boyle MP; Lai SK; Guggino WB; Hanes J
    J Control Release; 2014 Mar; 178():8-17. PubMed ID: 24440664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNSP113 (PAAG) improves mucociliary transport and lung pathology in the Scnn1b-Tg murine model of CF lung disease.
    Harris ES; Novak L; Fernandez-Petty CM; Lindgren NR; Baker SM; Birket SE; Rowe SM
    J Cyst Fibros; 2023 Nov; 22(6):1104-1112. PubMed ID: 37714777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. µCT to quantify muco-obstructive lung disease and effects of neutrophil elastase knockout in mice.
    Zhu L; Duerr J; Zhou-Suckow Z; Wagner W; Weinheimer O; Salomon J; Leitz D; Konietzke P; Yu H; Ackermann M; Stiller W; Kauczor HU; Mall MA; Wielpütz MO
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L401-L411. PubMed ID: 35080183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of IL-1 Receptor Signaling Reduces Spontaneous Airway Eosinophilia in Juvenile Mice with Muco-Obstructive Lung Disease.
    Brown R; Paulsen M; Schmidt S; Schatterny J; Frank A; Hirtz S; Delaney R; Doherty D; Hagner M; Taggart C; Weldon S; Mall MA
    Am J Respir Cell Mol Biol; 2020 Mar; 62(3):300-309. PubMed ID: 31499011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in whole lung and pulmonary macrophages reflects the dynamic pathology associated with airway surface dehydration.
    Saini Y; Dang H; Livraghi-Butrico A; Kelly EJ; Jones LC; O'Neal WK; Boucher RC
    BMC Genomics; 2014 Sep; 15(1):726. PubMed ID: 25204199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.
    Pangeni R; Meng T; Poudel S; Sharma D; Hutsell H; Ma J; Rubin BK; Longest W; Hindle M; Xu Q
    Int J Pharm; 2023 Mar; 634():122661. PubMed ID: 36736964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy.
    Duncan GA; Kim N; Colon-Cortes Y; Rodriguez J; Mazur M; Birket SE; Rowe SM; West NE; Livraghi-Butrico A; Boucher RC; Hanes J; Aslanidi G; Suk JS
    Mol Ther Methods Clin Dev; 2018 Jun; 9():296-304. PubMed ID: 30038933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Kcnn4 improves mucociliary clearance in muco-obstructive lung disease.
    Vega G; Guequén A; Philp AR; Gianotti A; Arzola L; Villalón M; Zegarra-Moran O; Galietta LJ; Mall MA; Flores CA
    JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Postnatal Secondhand Smoke Exposure Disrupts Bacterial Clearance and Abolishes Immune Responses in Muco-Obstructive Lung Disease.
    Lewis BW; Sultana R; Sharma R; Noël A; Langohr I; Patial S; Penn AL; Saini Y
    J Immunol; 2017 Aug; 199(3):1170-1183. PubMed ID: 28667160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases.
    Zhou-Suckow Z; Duerr J; Hagner M; Agrawal R; Mall MA
    Cell Tissue Res; 2017 Mar; 367(3):537-550. PubMed ID: 28108847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.
    Mastorakos P; da Silva AL; Chisholm J; Song E; Choi WK; Boyle MP; Morales MM; Hanes J; Suk JS
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8720-5. PubMed ID: 26124127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
    Giorgetti M; Klymiuk N; Bähr A; Hemmerling M; Jinton L; Tarran R; Malmgren A; Åstrand A; Hansson GC; Ermund A
    Eur J Pharmacol; 2021 Aug; 904():174123. PubMed ID: 33974881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy to enhance dendritic cell-mediated DNA vaccination in the lung.
    Kim YC; Hsueh HT; Kim N; Rodriguez J; Leo KT; Rao D; West NE; Hanes J; Suk JS
    Adv Ther (Weinh); 2021 Feb; 4(2):. PubMed ID: 33709020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.
    Schneider CS; Xu Q; Boylan NJ; Chisholm J; Tang BC; Schuster BS; Henning A; Ensign LM; Lee E; Adstamongkonkul P; Simons BW; Wang SS; Gong X; Yu T; Boyle MP; Suk JS; Hanes J
    Sci Adv; 2017 Apr; 3(4):e1601556. PubMed ID: 28435870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway epithelial cell-specific deletion of HMGB1 exaggerates inflammatory responses in mice with muco-obstructive airway disease.
    Mao Y; Patial S; Saini Y
    Front Immunol; 2022; 13():944772. PubMed ID: 36741411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.
    Terryah ST; Fellner RC; Ahmad S; Moore PJ; Reidel B; Sesma JI; Kim CS; Garland AL; Scott DW; Sabater JR; Carpenter J; Randell SH; Kesimer M; Abraham WM; Arendshorst WJ; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L192-L205. PubMed ID: 28982737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic airway epithelial hypoxia exacerbates injury in muco-obstructive lung disease through mucus hyperconcentration.
    Mikami Y; Grubb BR; Rogers TD; Dang H; Asakura T; Kota P; Gilmore RC; Okuda K; Morton LC; Sun L; Chen G; Wykoff JA; Ehre C; Vilar J; van Heusden C; Livraghi-Butrico A; Gentzsch M; Button B; Stutts MJ; Randell SH; O'Neal WK; Boucher RC
    Sci Transl Med; 2023 Jun; 15(699):eabo7728. PubMed ID: 37285404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.